Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction

Hypertension

Volumn 64, Issue 3, 2014, Pages 590-596

  Borges, Giulianna R ^a   Morgan, Donald A ^a   Ketsawatsomkron, Pimonrat ^a   Mickle, Aaron D ^a   Thompson, Anthony P ^a   Cassell, Martin D ^a   Mohapatra, Durga P ^a   Rahmouni, Kamal ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Baroreflex; Blood pressure; Heart rate; Muscle; Peroxisome proliferatoractivated receptors; Smooth; Sympathetic nervous system; Vascular

Indexed keywords

ACID SENSING ION CHANNEL; ACID-SENSING ION CHANNEL 2; ACID-SENSING ION CHANNEL 3; NITROPRUSSIDE SODIUM; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHENYLEPHRINE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC DYSFUNCTION; BAROREFLEX DYSFUNCTION; BLOOD VESSEL TONE; CAROTID ARTERY; CONTROLLED STUDY; HEART RATE; MEAN ARTERIAL PRESSURE; MOUSE; NERVE STIMULATION; NODOSE GANGLION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; TACHYCARDIA; TELEMETRY; VASCULAR SMOOTH MUSCLE; VASODILATATION;

BAROREFLEX; BLOOD PRESSURE; HEART RATE; MUSCLE, SMOOTH, VASCULAR; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SYMPATHETIC NERVOUS SYSTEM;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; BAROREFLEX; BLOOD PRESSURE; CALCIUM; CAPSAICIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEART RATE; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; NODOSE GANGLION; PPAR GAMMA; SIGNAL TRANSDUCTION; TACHYCARDIA;

EID: 84907598119     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03553     Document Type: Article

References (42)

1. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999;402:880-883.
2. Beyer AM, Baumbach GL, Halabi CM, Modrick ML, Lynch CM, Gerhold TD, Ghoneim SM, de Lange WJ, Keen HL, Tsai YS, Maeda N, Sigmund CD, Faraci FM. Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. Hypertension. 2008;51:867-871.
3. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension. 2004;43:661-666.
4. Halabi CM, Beyer AM, de Lange WJ, Keen HL, Baumbach GL, Faraci FM, Sigmund CD. Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. Cell Metab. 2008;7:215-226.
5. Ketsawatsomkron P, Lorca RA, Keen HL, Weatherford ET, Liu X, Pelham CJ, Grobe JL, Faraci FM, England SK, Sigmund CD. PPARgamma regulates resistance vessel tone through a mechanism involving RGS5-mediated control of PKC and BKCa channel activity. Circ Res. 2012;111:1446-1458.
6. Pelham CJ, Ketsawatsomkron P, Groh S, Grobe JL, de Lange WJ, Ibeawuchi SR, Keen HL, Weatherford ET, Faraci FM, Sigmund CD. Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase. Cell Metab. 2012;16:462-472.
7. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 1994;74:323-364.
8. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058-1066.
9. Ma X, Abboud FM, Chapleau MW. Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol. 2002;283:R1033-R1040.
10. Liu C, Bookout AL, Lee S, Sun K, Jia L, Lee C, Udit S, Deng Y, Scherer PE, Mangelsdorf DJ, Gautron L, Elmquist JK. PPARγ in vagal neurons regulates high-fat diet induced thermogenesis. Cell Metab. 2014;19:722-730.
11. Lu Y, Ma X, Sabharwal R, Snitsarev V, Morgan D, Rahmouni K, Drummond HA, Whiteis CA, Costa V, Price M, Benson C, Welsh MJ, Chapleau MW, Abboud FM. The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation. Neuron. 2009;64:885-897.
12. Sun H, Li DP, Chen SR, Hittelman WN, Pan HL. Sensing of blood pressure increase by transient receptor potential vanilloid 1 receptors on baroreceptors. J Pharmacol Exp Ther. 2009;331:851-859.
13. Li L, Huang C, Ai J, Yan B, Gu H, Ma Z, Li AY, Xinyan S, Harden SW, Hatcher JT, Wurster RD, Cheng ZJ. Structural remodeling of vagal afferent innervation of aortic arch and nucleus ambiguus (NA) projections to cardiac ganglia in a transgenic mouse model of type 1 diabetes (OVE26). J Comp Neurol. 2010;518:2771-2793.
14. Loo L, Shepherd AJ, Mickle AD, Lorca RA, Shutov LP, Usachev YM, Mohapatra DP. The C-type natriuretic peptide induces thermal hyperalgesia through a noncanonical Gβγ-dependent modulation of TRPV1 channel. J Neurosci. 2012;32:11942-11955.
15. Kleinhenz JM, Kleinhenz DJ, You S, Ritzenthaler JD, Hansen JM, Archer DR, Sutliff RL, Hart CM. Disruption of endothelial peroxisome proliferator- Activated receptor-gamma reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol. 2009;297:H1647-H1654.
16. Nicol CJ, Adachi M, Akiyama TE, Gonzalez FJ. PPARgamma in endothelial cells influences high fat diet-induced hypertension. Am J Hypertens. 2005;18(4 pt 1):549-556.
17. Beyer AM, de Lange WJ, Halabi CM, Modrick ML, Keen HL, Faraci FM, Sigmund CD. Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. Circ Res. 2008;103:654-661.
18. Subramanian V, Golledge J, Ijaz T, Bruemmer D, Daugherty A. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}. Circ Res. 2010;107:953-958.
19. Marchesi C, Rehman A, Rautureau Y, Kasal DA, Briet M, Leibowitz A, Simeone SM, Ebrahimian T, Neves MF, Offermanns S, Gonzalez FJ, Paradis P, Schiffrin EL. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. Cardiovasc Res. 2013;97:562-570.
20. Chapleau MW, Sabharwal R. Methods of assessing vagus nerve activity and reflexes. Heart Fail Rev. 2011;16:109-127.
21. Lohmeier TE, Iliescu R. Chronic activation of the baroreflex and the promise for hypertension therapy. Handb Clin Neurol. 2013;117:395-406.
22. Huber DA, Schreihofer AM. Attenuated baroreflex control of sympathetic nerve activity in obese Zucker rats by central mechanisms. J Physiol. 2010;588(pt 9):1515-1525.
23. Nakamura Y, Takeda K, Nakata T, Hayashi J, Kawasaki S, Lee LC, Sasaki S, Nakagawa M, Ijichi H. Central attenuation of aortic baroreceptor reflex in prehypertensive DOCA-salt-loaded rats. Hypertension. 1988;12:259-266.
24. Gonzalez ER, Krieger AJ, Sapru HN. Central resetting of baroreflex in the spontaneously hypertensive rat. Hypertension. 1983;5:346-352.
25. Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM. Structural versus functional modulation of the arterial baroreflex. Hypertension. 1995;26:341-347.
26. Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo. Circulation. 2003;107:2480-2486.
27. Sapru HN, Wang SC. Modification of aortic barorecptor resetting in the spontaneously hypertensive rat. Am J Physiol. 1976;230:664-674.
28. Pelham CJ, Keen HL, Lentz SR, Sigmund CD. Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle. Am J Physiol Regul Integr Comp Physiol. 2013;304:R690-R701.
29. Gollasch M, Tank J, Luft FC, Jordan J, Maass P, Krasko C, Sharma AM, Busjahn A, Bähring S. The BK channel beta1 subunit gene is associated with human baroreflex and blood pressure regulation. J Hypertens. 2002;20:927-933.
30. Bernardo A, Ajmone-Cat MA, Gasparini L, Ongini E, Minghetti L. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen. J Neurochem. 2005;92:895-903.
31. Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience. 2005;130:325-337.
32. Lu M, Sarruf DA, Talukdar S, Sharma S, Li P, Bandyopadhyay G, Nalbandian S, Fan W, Gayen JR, Mahata SK, Webster NJ, Schwartz MW, Olefsky JM. Brain PPAR-γ promotes obesity and is required for the insulin- sensitizing effect of thiazolidinediones. Nat Med. 2011;17:618-622.
33. Ryan KK, Li B, Grayson BE, Matter EK, Woods SC, Seeley RJ. A role for central nervous system PPAR-γ in the regulation of energy balance. Nat Med. 2011;17:623-626.
34. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 1997;389:816-824.
35. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139:267-284.
36. Wu JS, Lu FH, Yang YC, Chang SH, Huang YH, Chen JJ, Chang CJ. Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose [published online ahead of print January 2014]. Acta Diabetol. doi: 10.1007/s00592-013-0548-9. http://link.springer.com/ article/10.1007%2Fs00592-013-0548-9. Accessed June 2, 2014.
37. Frattola A, Parati G, Gamba P, Paleari F, Mauri G, Di Rienzo M, Castiglioni P, Mancia G. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia. 1997;40:1470-1475.
38. Maeda CY, Fernandes TG, Timm HB, Irigoyen MC. Autonomic dysfunction in short-term experimental diabetes. Hypertension. 1995;26(6 pt 2):1100-1104.
39. Lin M, Harden SW, Li L, Wurster RD, Cheng ZJ. Impairment of baroreflex control of heart rate in conscious transgenic mice of type 1 diabetes (OVE26). Auton Neurosci. 2010;152:67-74.
40. Okada N, Takahashi N, Yufu K, Murozono Y, Wakisaka O, Shinohara T, Anan F, Nakagawa M, Hara M, Saikawa T, Yoshimatsu H. Baroreflex sensitivity predicts cardiovascular events in patients with type 2 diabetes mellitus without structural heart disease. Circ J. 2010;74:1379-1383.
41. Yokoe H, Yuasa F, Yuyama R, Murakawa K, Miyasaka Y, Yoshida S, Tsujimoto S, Sugiura T, Iwasaka T. Effect of pioglitazone on arterial baroreflex sensitivity and sympathetic nerve activity in patients with acute myocardial infarction and type 2 diabetes mellitus. J Cardiovasc Pharmacol. 2012;59:563-569.
42. Zhao D, McCully BH, Brooks VL. Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity. J Pharmacol Exp Ther. 2012;343:206-213.